Inspire Investing’s Dr. Reddy's Laboratories RDY Stock Holding History

Inspire Investing’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$565	Buy	39 +1	+3%	+$13	﹤0.01%	1195
2026 Q1	$524	Sell	38 -3	-7%	-$42	﹤0.01%	1046
2025 Q4	$579	Buy	+41	New	+$575	﹤0.01%	1042
2024 Q4	–	Sell	-57,740	Closed	-$917K	–	854
2024 Q3	$917K	Sell	57,740 -7,120	-11%	-$115K	0.09%	219
2024 Q2	$988K	Sell	64,860 -15,150	-19%	-$217K	0.11%	213
2024 Q1	$1.17M	Sell	80,010 -51,765	-39%	-$756K	0.12%	204
2023 Q4	$1.83M	Buy	131,775 +56,820	+76%	+$760K	0.2%	115
2023 Q3	$1M	Sell	74,955 -54,140	-42%	-$732K	0.13%	187
2023 Q2	$1.63M	Buy	129,095 +79,425	+160%	+$927K	0.2%	124
2023 Q1	$566K	Buy	+49,670	New	+$536K	0.07%	202
2018 Q1	–	Sell	-3,600	Closed	-$27K	–	583
2017 Q4	$27K	Buy	+3,600	New	+$25.9K	0.02%	764

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Inspire Investing's RDY Position: Q2 2026 in Review

Inspire Investing increased its Dr. Reddy's Laboratories (RDY) stake by 2.6% in Q2 2026, buying an estimated $13 and bringing the position to 39 shares worth $565. The position accounts for ﹤0.01% of the portfolio, ranked #1195.

Inspire Investing first reported a position in RDY in Q4 2017 and has held it in 11 quarters since. The position peaked at $1.83M in Q4 2023. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Inspire Investing held 39 shares of Dr. Reddy's Laboratories worth $565 as of Q2 2026.
Inspire Investing bought 1 Dr. Reddy's Laboratories share in Q2 2026, an estimated $13.
Dr. Reddy's Laboratories made up ﹤0.01% of Inspire Investing's portfolio in Q2 2026, its #1195 holding.
Inspire Investing first reported a position in Dr. Reddy's Laboratories in Q4 2017 and has held it in 11 quarters since.
Inspire Investing's Dr. Reddy's Laboratories position peaked at $1.83M in Q4 2023.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.